{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:09:08Z","timestamp":1761844148115},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The purpose of this study was to evaluate acute and late toxicities of radiotherapy for patients with discoid lupus erythematosus (DLE).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective review was performed of patients with DLE who received radiotherapy at our institution between 1980 and 2005. Patients with other connective tissue disorders were excluded. Control patients were matched 2:1 with the DLE treatment courses based on age, cancer diagnosis, year of treatment, radiotherapy dose, and sex. Acute (within 30 days from the completion of radiotherapy) and late toxicities were evaluated for each treatment course using the Common Terminology Criteria for Adverse Events Version 3.0.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twelve patients with DLE received a total of 15 radiotherapy courses. The median follow-up time was 2.6 years (range, 0.0-15.2 years). Acute toxicity of any organ was observed in 10 (67%) treatment courses, of which 2 (13%) were Grade 3 or higher. Acute Grade 1 or 2 dermatologic toxicity was observed in 8 courses (53%). Late toxicity of any organ was observed in 7 of 12 (58%) evaluable treatment courses, of which 3 (23%) were grade 3 or higher. Late grade 1 or 2 dermatologic toxicity was observed in 5 (42%) courses. No patient experienced acute or late Grade 3 or higher dermatologic toxicity. The rates of any organ or dermatologic acute and late toxicity were not significantly different between DLE and control treatment courses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings do not suggest an increased risk of toxicity to the skin or other organs in patients with DLE receiving radiotherapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1748-717x-7-22","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T17:14:25Z","timestamp":1329412465000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Acute and late toxicities of radiotherapy for patients with discoid lupus erythematosus: a retrospective case-control study"],"prefix":"10.1186","volume":"7","author":[{"given":"Ajaykumar B","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L","family":"Hallemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivy A","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley W","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,16]]},"reference":[{"issue":"2","key":"521_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3122\/jabfm.2009.02.080075","volume":"22","author":"S Panjwani","year":"2009","unstructured":"Panjwani S: Early diagnosis and treatment of discoid lupus erythematosus. J Am Board Fam Med 2009,22(2):206-213. 10.3122\/jabfm.2009.02.080075","journal-title":"J Am Board Fam Med"},{"issue":"4","key":"521_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaad.2008.11.904","volume":"60","author":"A Erceg","year":"2009","unstructured":"Erceg A, Bovenschen HJ, van de Kerkhof PC, de Jong EM, Seyger MM: Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus. J Am Acad Dermatol 2009,60(4):626-632. 10.1016\/j.jaad.2008.11.904","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"521_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00105-009-1767-4","volume":"61","author":"N Booken","year":"2010","unstructured":"Booken N, Schumann T, Fuchslocher M, Goerdt S, Goebeler M: Successful therapy of discoid lupus erythematosus with efalizumab. Hautarzt 2010,61(3):246-249. German 10.1007\/s00105-009-1767-4","journal-title":"Hautarzt"},{"issue":"2","key":"521_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1365-2230.2005.02030.x","volume":"31","author":"A Mitra","year":"2006","unstructured":"Mitra A, Yung A, Goulden V, Goodfield MD: A trial of low-dose UVA1 phototherapy for two patients with recalcitrant discoid lupus erythematosus. Clin Exp Dermatol 2006,31(2):299-300. 10.1111\/j.1365-2230.2005.02030.x","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"521_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0360-3016(99)00103-0","volume":"44","author":"B De Naeyer","year":"1999","unstructured":"De Naeyer B, De Meerleer G, Braems S, Vakaet L, Huys J: Collagen vascular diseases and radiation therapy: a critical review. Int J Radiat Oncol Biol Phys 1999,44(5):975-980. 10.1016\/S0360-3016(99)00103-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"521_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.radonc.2005.12.013","volume":"78","author":"T Holscher","year":"2006","unstructured":"Holscher T, Bentzen SM, Baumann M: Influence of connective tissue diseases on the expression of radiation side effects: a systematic review. Radiother Oncol 2006,78(2):123-130. 10.1016\/j.radonc.2005.12.013","journal-title":"Radiother Oncol"},{"issue":"3","key":"521_CR7","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/cncr.23591","volume":"113","author":"A Lin","year":"2008","unstructured":"Lin A, Abu-Isa E, Griffith KA, Ben-Josef E: Toxicity of radiotherapy in patients with collagen vascular disease. Cancer 2008,113(3):648-653. 10.1002\/cncr.23591","journal-title":"Cancer"},{"issue":"2","key":"521_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijrobp.2006.09.003","volume":"67","author":"DG Gold","year":"2007","unstructured":"Gold DG, Miller RC, Petersen IA, Osborn TG: Radiotherapy for malignancy in patients with scleroderma: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys 2007,67(2):559-67. 10.1016\/j.ijrobp.2006.09.003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"521_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2007.10.014","volume":"71","author":"ME Pinn","year":"2008","unstructured":"Pinn ME, Gold DG, Petersen IA, Osborn TG, Brown PD, Miller RC: Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys 2008,71(2):498-506. 10.1016\/j.ijrobp.2007.10.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"521_CR10","unstructured":"2006.http:\/\/ctep.cancer.gov Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003"},{"issue":"5","key":"521_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958,53(5):457-481.","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"521_CR12","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1002\/1097-0142(19930601)71:11<3744::AID-CNCR2820711144>3.0.CO;2-C","volume":"71","author":"JG Ross","year":"1993","unstructured":"Ross JG, Hussey DH, Mayr NA, Davis CS: Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer 1993,71(11):3744-3752. 10.1002\/1097-0142(19930601)71:11<3744::AID-CNCR2820711144>3.0.CO;2-C","journal-title":"Cancer"},{"issue":"1","key":"521_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0009-9260(89)80040-6","volume":"40","author":"IA Olivotto","year":"1989","unstructured":"Olivotto IA, Fairey RN, Gillies JH, Stein H: Fatal outcome of pelvic radiotherapy for carcinoma of the cervix in a patient with systemic lupus erythematosis. Clin Radiol 1989,40(1):83-84. 10.1016\/S0009-9260(89)80040-6","journal-title":"Clin Radiol"},{"issue":"3","key":"521_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/1097-0142(19910801)68:3<502::AID-CNCR2820680310>3.0.CO;2-V","volume":"68","author":"JM Robertson","year":"1991","unstructured":"Robertson JM, Clarke DH, Pevzner MM, Matter RC: Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer 1991,68(3):502-508. 10.1002\/1097-0142(19910801)68:3<502::AID-CNCR2820680310>3.0.CO;2-V","journal-title":"Cancer"},{"issue":"4","key":"521_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/0360-3016(89)90074-6","volume":"17","author":"R Fleck","year":"1989","unstructured":"Fleck R, McNeese MD, Ellerbroek NA, Hunter TA, Holmes FA: Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys 1989,17(4):829-833. 10.1016\/0360-3016(89)90074-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"521_CR16","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.1997.15.7.2728","volume":"15","author":"MM Morris","year":"1997","unstructured":"Morris MM, Powell SN: Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol 1997,15(7):2728-2735.","journal-title":"J Clin Oncol"},{"issue":"6","key":"521_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/00130404-200311000-00005","volume":"9","author":"C Phan","year":"2003","unstructured":"Phan C, Mindrum M, Silverman C, Paris K, Spanos W: Matched-control retrospective study of the acute and late complications in patients with collagen vascular diseases treated with radiation therapy. Cancer J 2003,9(6):461-466. 10.1097\/00130404-200311000-00005","journal-title":"Cancer J"},{"issue":"6","key":"521_CR18","first-page":"480","volume":"7","author":"AM Chen","year":"2001","unstructured":"Chen AM, Obedian E, Haffty BG: Breast-conserving therapy in the setting of collagen vascular disease. Cancer J 2001,7(6):480-491.","journal-title":"Cancer J"},{"issue":"1","key":"521_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.radonc.2007.11.031","volume":"87","author":"DG Gold","year":"2008","unstructured":"Gold DG, Miller RC, Pinn ME, Osborn TG, Petersen IA, Brown PD: Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: association with connective tissue disorder severity. Radiother Oncol 2008,87(1):127-131. 10.1016\/j.radonc.2007.11.031","journal-title":"Radiother Oncol"},{"issue":"1","key":"521_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/art.20912","volume":"53","author":"V Benk","year":"2005","unstructured":"Benk V, Al-Herz A, Gladman D, Urowitz M, Fortin PR: Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer. Arthritis Rheum 2005,53(1):67-72. 10.1002\/art.20912","journal-title":"Arthritis Rheum"},{"issue":"3","key":"521_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2230.1988.tb01972.x","volume":"13","author":"DJ Eedy","year":"1988","unstructured":"Eedy DJ, Corbett JR: Discoid lupus erythematosus exacerbated by x-ray irradiation. Clin Exp Dermatol 1988,13(3):202-203. 10.1111\/j.1365-2230.1988.tb01972.x","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"521_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1346-8138.2005.tb00752.x","volume":"32","author":"A Ishida-Yamamoto","year":"2005","unstructured":"Ishida-Yamamoto A, Kanno K, Sato E, Takahashi H, Iizuka H: Discoid lupus erythematosus exacerbated by radiation therapy. J Dermatol 2005,32(3):225-226.","journal-title":"J Dermatol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:29:52Z","timestamp":1630520992000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-7-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-7-22","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,16]]},"assertion":[{"value":"30 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}